Chronic Obstructive Pulmonary Disease Patient Preferences Survey
COPD Patient Preferences, Activities, and Participation Survey
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedFirst Posted
Study publicly available on registry
November 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2018
CompletedResults Posted
Study results publicly available
December 24, 2020
CompletedDecember 24, 2020
December 1, 2020
11 months
April 26, 2016
August 11, 2020
December 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants Who Prioritized Healthcare Topics
Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Prioritized Research Topics
Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below. Activity 1: Walking from one place to another outside of your home on a flat surface. Activity 2: Moving from one place to another using motorized transportation. Activity 3: Climbing two or more flights of stairs. Activity 4: Walking up a hill. Activity 5: Participating in regular exercise. Activity 6: Walking from one place to another in your home. Activity 7: Carrying light objects on a flat surface. Activity 8: Carrying heavy objects on a flat surface. Activity 9: Carrying-out low intensity physical activities
Baseline
Secondary Outcomes (7)
Forced Expiratory Volume in 1-sec (FEV1)
Baseline
FEV1/FVC
Baseline
Modified Medical Research Council Questionnaire on Breathlessness
Baseline
COPD Assessment Test
Baseline
Godin Leisure Time Physical Activity Questionnaire
Baseline
- +2 more secondary outcomes
Study Arms (4)
Quartile 1 [Mild]
Quartile 2 [Moderate]
Quartile 3 [Severe]
Quartile 4 [Very Severe]
Interventions
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Eligibility Criteria
Adults living with chronic obstructive pulmonary disease (COPD).
You may qualify if:
- Clinical diagnosis of COPD
- English or French speaking
- Patient at one of the three participating sites with medical chart
You may not qualify if:
- No diagnosis of COPD by a healthcare professional
- Unable to communicate in English or French
- Unable to provide informed consent
- No medical chart information at one of the three participating sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- AstraZenecacollaborator
Study Sites (1)
Montreal Chest Institute of the McGill University Health Center (MUHC)
Montreal, Quebec, H4A 3J1, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Emilie Michalovic, Ph.D. Candidate
- Organization
- McGill University
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis Jensen, Ph.D.
McGill University
- PRINCIPAL INVESTIGATOR
Shane N Sweet, Ph.D.
McGill University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 26, 2016
First Posted
November 22, 2016
Study Start
November 1, 2016
Primary Completion
October 1, 2017
Study Completion
December 12, 2018
Last Updated
December 24, 2020
Results First Posted
December 24, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share